A medicinal product may only be classified as a prescription-only medicine if the restrictions on prescribing are justified by the constraints involved in implementing the treatment, having regard to the specific nature of the pathology and the pharmacological characteristics of the medicinal product, its degree of innovation, or another public health reason.